Atypical parathyroid adenoma

Case contributed by Mikkaela McCormack , 12 Jul 2016
Diagnosis certain
Changed by Henry Knipe, 7 Feb 2017
Hidden edits. Some edits not affecting the appearance of this case have been suppressed.

Updates to Case Attributes

Age changed from 53 to 55 years.
Suitable For Quiz was set to .
Body was changed:

The presence of a fibrous capsule and traversing thick, hyalinised fibrous bands seen in this case are not usually seen within a regular parathyroid adenoma and are a noted feature of atypical parathyroid adenoma, along with a solid and trabecular growth pattern and scattered mitotic figures. 

Parathyroid Carcinomacarcinoma vs. Atypical Parathyroid Adenoma atypical parathyroid adenoma

Parathyroid CarcinomacarcinomaThe definitive diagnosis of parathyroid carcinoma is the presence of metastatic disease or localised invasion into surrounding structures.  HistologicalHistological features of parathyroid carcinoma include:-  Capsule

  • capsule invasion and involvement of surrounding structures-  Lymphovascular / Perineural
  • lymphovascular/perineural invasion-  Elevated
  • elevated mitotic rate with atypical mitotic figures

Atypical Parathyroid Adenomaparathyroid adenomaAtypical adenomas lack the definitive evidence of parathyroid carcinoma but display some abnormal features:-  Thick

  • thick hyalinised fibrous bands-  Incomplete
  • incomplete capsular invasion-  Prominent
  • prominent trabecular growth pattern-  Necrosis
  • necrosis (real, tumour-associated necrosis)-  Increased
  • increased mitotic rate (>1/10hpf) -  uncommonuncommon

Note:  AdenomasAdenomas likely need to show more than just one abnormal feature to be designated as 'atypical', with some suggesting 2+ to qualify for a diagnosis.

ImmunohistochemistryPTH is a great stain to determine the parathyroid nature of the cells.   There aren'tThere are not any definitive or diagnostic immunohistochemical stains you can use to distinguish between benign and malignant (or potentially malignant) parathyroid neoplasms, however, the following have been used in research settings:

Adenoma (vs. 'Normal 'normal'):  neurofilament, GFAP, vimentin, less intense PTH and chromograninParathyroid Carcinoma:  Ki67, galectin-3, cyclin D1, bcl2, MDM2

  • -<p>The presence of a fibrous capsule and traversing thick, hyalinised fibrous bands seen in this case are not usually seen within a regular parathyroid adenoma and are a noted feature of atypical parathyroid adenoma, along with a solid and trabecular growth pattern and scattered mitotic figures. </p><p><strong>Parathyroid Carcinoma vs. Atypical Parathyroid Adenoma</strong></p><p><em>Parathyroid Carcinoma</em><br>The definitive diagnosis of parathyroid carcinoma is the presence of metastatic disease or localised invasion into surrounding structures.  Histological features of parathyroid carcinoma include:<br>-  Capsule invasion and involvement of surrounding structures<br>-  Lymphovascular / Perineural invasion<br>-  Elevated mitotic rate with atypical mitotic figures</p><p><em>Atypical Parathyroid Adenoma</em><br>Atypical adenomas lack the definitive evidence of parathyroid carcinoma but display some abnormal features:<br>-  Thick hyalinised fibrous bands<br>-  Incomplete capsular invasion<br>-  Prominent trabecular growth pattern<br>-  Necrosis (real, tumour-associated necrosis)<br>-  Increased mitotic rate (&gt;1/10hpf)  -  uncommon</p><p>Note:  Adenomas likely need to show more than just one abnormal feature to be designated as 'atypical', with some suggesting 2+ to qualify for a diagnosis.</p><p><strong>Immunohistochemistry</strong><br>PTH is a great stain to determine the parathyroid nature of the cells.   There aren't any definitive or diagnostic immunohistochemical stains you can use to distinguish between benign and malignant (or potentially malignant) parathyroid neoplasms, however, the following have been used in research settings:</p><p>Adenoma (vs. 'Normal'):  neurofilament, GFAP, vimentin, less intense PTH and chromogranin<br>Parathyroid Carcinoma:  Ki67, galectin-3, cyclin D1, bcl2, MDM2</p>
  • +<p>The presence of a fibrous capsule and traversing thick, hyalinised fibrous bands seen in this case are not usually seen within a regular parathyroid adenoma and are a noted feature of atypical parathyroid adenoma, along with a solid and trabecular growth pattern and scattered mitotic figures. </p><p><strong>Parathyroid carcinoma vs atypical parathyroid adenoma</strong></p><p><em>Parathyroid carcinoma</em><br>The definitive diagnosis of parathyroid carcinoma is the presence of metastatic disease or localised invasion into surrounding structures. Histological features of parathyroid carcinoma include:</p><ul>
  • +<li>capsule invasion and involvement of surrounding structures</li>
  • +<li>lymphovascular/perineural invasion</li>
  • +<li>elevated mitotic rate with atypical mitotic figures</li>
  • +</ul><p><em>Atypical parathyroid adenoma</em><br>Atypical adenomas lack the definitive evidence of parathyroid carcinoma but display some abnormal features:</p><ul>
  • +<li>thick hyalinised fibrous bands</li>
  • +<li>incomplete capsular invasion</li>
  • +<li>prominent trabecular growth pattern</li>
  • +<li>necrosis (real, tumour-associated necrosis)</li>
  • +<li>increased mitotic rate (&gt;1/10hpf) - uncommon</li>
  • +</ul><p>Note: Adenomas likely need to show more than just one abnormal feature to be designated as 'atypical', with some suggesting 2+ to qualify for a diagnosis.</p><p><strong>Immunohistochemistry</strong><br>PTH is a great stain to determine the parathyroid nature of the cells. There are not any definitive or diagnostic immunohistochemical stains you can use to distinguish between benign and malignant (or potentially malignant) parathyroid neoplasms, however, the following have been used in research settings:</p><p>Adenoma (vs 'normal'):  neurofilament, GFAP, vimentin, less intense PTH and chromogranin<br>Parathyroid Carcinoma:  Ki67, galectin-3, cyclin D1, bcl2, MDM2</p>

References changed:

  • 1. Rodriguez C, Nadéri S, Hans C, Badoual C. Parathyroid carcinoma: a difficult histological diagnosis. (2012) European annals of otorhinolaryngology, head and neck diseases. 129 (3): 157-9. <a href="https://doi.org/10.1016/j.anorl.2012.01.002">doi:10.1016/j.anorl.2012.01.002</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22480967">Pubmed</a> <span class="ref_v4"></span>
  • 2. Carlson D. Parathyroid pathology: hyperparathyroidism and parathyroid tumors. (2010) Archives of pathology & laboratory medicine. 134 (11): 1639-44. <a href="https://doi.org/10.1043/2009-0578-CCR.1">doi:10.1043/2009-0578-CCR.1</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21043817">Pubmed</a> <span class="ref_v4"></span>
  • Rodriguez C, Nadéri S, Hans C, Badoual C Parathyroid carcinoma: A difficult histological diagnosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):157-9 (open/free access) http://www.sciencedirect.com/science/article/pii/S1879729612000348 Rodriguez C, Nadéri S, Hans C, Badoual C Parathyroid carcinoma: A difficult histological diagnosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):157-9 (open/free access) Carlson D. Parathyroid pathology: hyperparathyroidism and parathyroid tumors. Arch Pathol Lab Med. 2010 Nov;134(11):1639-44 (open/free access) http://www.archivesofpathology.org/doi/pdf/10.1043/2009-0578-CCR.1

How to use cases

You can use Radiopaedia cases in a variety of ways to help you learn and teach.

Creating your own cases is easy.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.